TWO doses of the Pfizer/BioNTech coronavirus vaccine prevents 99.96 per cent of cases, a new study suggests.
The jab is currently being rolled out across the UK alongside the Oxford vaccine, with more than 7.4 million Brits having received their first dose.
Experts have revealed that the Pfizer jab prevents 99.96 per cent of Covid casesCredit: Reuters
An Israeli study suggests that just 0.04 per cent of people who received both doses of the Pfizer jab went on to develop Covid-19.
Israel has been at the forefront of the vaccine rollout having started its rollout on December 19.
In the space of just three weeks, the country had managed to inoculate 20 per cent of the population with a first dose.
Just over a month on and more than 30 per cent of the Israeli population has received a jab.
Data published by Israeli health officials showed that of 700,000 people vaccinated, just 300 contracted the illness.
Just 16 needed to receive hospital treatment, the data showed.
The experts also said that the vaccine protects against the UK variant of the virus that was first discovered in Kent in September 2020.
Professor Eyal Leshem, an Israeli infectious diseases specialist, said the reports were “very good news” and stated that the initial findings were “quite incredible”.
He added: “Time will tell, we still need to accumulate data but these are very encouraging preliminary reports.”
The study was led by Maccabi Healthcare Services and the firm said that it is “the first study in the world that looks at such a large number of fully vaccinated patients”.
Israel is currently experiencing around 1,000 new Covid cases a day – the highest rate the country has seen since the start of the pandemic.
Prof Leshem added that the study found that those who were already vaccinated were not becoming infected.
He said in the “few cases” they had seen, these people had experienced mild symptoms.
He continued: “It’s what we call real life, ecologic evidence of vaccine efficacy – the high efficacy of the vaccine.”
Israeli officials are providing the team at Pfizer with weekly updates on its vaccine campaign as part of a collaborative effort.
The news of the Pfizer jab’s efficiency comes after it was today announced that the first one dose Covid vaccine is 72 per cent effective.
The Government has already ordered 30million doses of Janssen jab, developed by Johnson & Johnson.
Trials in the US found the jab was 72 per cent effective, while those in South Africa – where the new and more contagious strain is prevalent – found it was 57 per cent effective.
Earlier today it was also reported that the Novavax jab is effective in 89.3 per cent of cases.